Literature DB >> 6436194

Pulmonary aspiration in tube-fed patients with artificial airways.

D M Treloar, J Stechmiller.   

Abstract

Based on the results of this study, it appears that critically ill patients may receive nutritional supplements through the use of a small-gauge, flexible enteral feeding tube without significant danger of pulmonary aspiration. However, the potential for aspiration of tube feedings in any critically ill patient still exists, and further research in this area would contribute to a decrease in morbidity and mortality rates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436194

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  5 in total

1.  Fiberoptic endoscopic evaluation of swallowing (FEES) with and without blue-dyed food.

Authors:  Steven B Leder; Lynn M Acton; Heather L Lisitano; Joseph T Murray
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

2.  Stress ulcer prophylaxis and the risk of nosocomial pneumonia in artificially ventilated patients.

Authors:  F Daschner
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

3.  Pneumonia in acute stroke patients fed by nasogastric tube.

Authors:  R Dziewas; M Ritter; M Schilling; C Konrad; S Oelenberg; D G Nabavi; F Stögbauer; E B Ringelstein; P Lüdemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

Review 4.  Enteral nutrition as a risk factor for nosocomial pneumonia.

Authors:  S K Pingleton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

Review 5.  Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.

Authors:  R G Masterton; A Galloway; G French; M Street; J Armstrong; E Brown; J Cleverley; P Dilworth; C Fry; A D Gascoigne; Alan Knox; Dilip Nathwani; Robert Spencer; Mark Wilcox
Journal:  J Antimicrob Chemother       Date:  2008-04-29       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.